Is it justified to perform a bone marrow biopsy examination in sustained erythrocytosis?

Current Hematologic Malignancy Reports

Volumn 1, Issue 2, 2006, Pages 87-92

  Thiele, Juergen ^a   Kvasnicka, Hans Michael ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW BIOPSY; CELL DIFFERENTIATION; CELL SIZE; ERYTHROCYTOSIS; HISTOPATHOLOGY; HUMAN; MEGAKARYOPOIESIS; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; REVIEW; THROMBOCYTE COUNT;

AGED; BLAST CRISIS; BONE MARROW CELLS; BONE MARROW EXAMINATION; CELL LINEAGE; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; FIBROSIS; HUMANS; IRON; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; POLYCYTHEMIA; POLYCYTHEMIA VERA; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; STROMAL CELLS; THROMBOCYTHEMIA, ESSENTIAL; UNNECESSARY PROCEDURES;

EID: 33750363361     PISSN: 15588211     EISSN: 1558822X     Source Type: Journal    
DOI: 10.1007/s11899-006-0028-1     Document Type: Review

References (47)

1. Streiff MB, Smith B, Spivak JL: The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns. Blood 2002, 99:1144-1149. This comprehensive study elegantly describes the state of art regarding diagnosis and management of polycythemia vera (PV) in the United States.
2. Tefferi A, Spivak JL: Polycythemia vera: scientific advances and current practice. Semin Hematol 2005, 42:206-220. A very recent review of basic scientific and clinical aspects of PV, including a critical attitude towards the determination of the red cell mass as the major diagnostic feature and the performance of a bone marrow biopsy examination.
3. Spivak JL: Polycythemia vera: myths, mechanisms, and management. Blood 2002, 100:4272-4290. An outstanding and thorough review of the multiple aspects of PV, with a critical discussion of the diagnostic value of bone marrow biopsies.
4. Murphy S: Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia. Semin Hematol 1999, 36:9-13.
5. Berlin NI: Diagnosis and classification of the polycythemias. Semin Hematol 1975, 12:339-351.
6. Bilgrami S, Greenberg BR: Polycythemia rubra vera. Semin Oncol 1995, 22:307-326.
7. Pearson TC: Diagnosis and classification of erythrocytoses and thrombocytoses. Baillieres Clin Haematol 1998, 11:695-720.
8. Pearson TC: Evaluation of diagnostic criteria in polycythemia vera. Semin Hematol 2001, 38:21-24.
9. Pierre R, Imbert M, Thiele J, et al.: Polycythemia vera. In WHO Classification of Tumours: Tumours of Hematopoietic and Lymphoid Tissue. Edited by Jaffe ES, Harris NL, Stein H, et al. Lyon, France: IARC Press; 2001:32-38. This chapter includes the new World Health Organization (WHO) classification of PV in which, for the first time, bone marrow morphology is regarded as a minor criterion.
10. Michiels JJ, Thiele J: Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia). Int J Hematol 2002, 76:133-145. This paper reviews clinical as well as morphologic findings in chronic myeloproliferative disorders, including PV. In confirmation and extension of the WHO diagnostic guidelines (see reference 9), the paper introduces the so-called European clinicopathological criteria.
11. Ellis JT, Silver RT, Coleman M, et al.: The bone marrow in polycythemia vera. Semin Hematol 1975, 12:433-444.
12. Peterson P, Ellis TJ: The bone marrow in polycythemia vera. In Polycythemia Vera and the Myeloproliferative Disorders. Edited by Wasserman LR, Berk PD, Berlin NI. Philadelphia: WB Saunders; 1995:31-53.
13. Ellis JT, Peterson P: The bone marrow in polycythemia vera. Pathol Annu 1979, 14:383-403.
14. Iland HJ, Laszlo J, Case DC, Jr., et al.: Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosis. Am J Hematol 1987, 25:191-201.
15. Georgii A, Buesche G, Kreft A: The histopathology of chronic myeloproliferative diseases. Baillieres Clin Haematol 1998, 11:721-749. This review thoroughly describes bone marrow findings in chronic myeloproliferative disorders, including PV.
16. Thiele J, Kvasnicka HM: Diagnostic impact of bone marrow histopathology in polycythemia vera (PV). Histol Histopathol 2005, 20:317-328. This review article on bone marrow morphology in all stages of PV is based on a large cohort of patients and tries to elucidate the dynamics of the disease process.
17. Thiele J, Kvasnicka HM, Orazi A: Bone marrow histopathology in myeloproliferative disorders-current diagnostic approach. Semin Hematol 2005, 42:184-195.
18. Thiele J, Kvasnicka HM, Zankovich R, et al.: The value of bone marrow histology in differentiating between early stage polycythemia vera and secondary (reactive) polycythemias. Haematologica 2001, 86:368-374. This is the first paper discriminating early initial stages of PV from secondary polycythemia based on histomorphologic criteria evaluated in a blinded and independent fashion.
19. Thiele J, Kvasnicka HM, Diehl V: Standardization of bone marrow features-does it work in hematopathology for histological discrimination of different disease patterns? Histol Histopathol 2005, 20:633-644.
20. Thiele J, Kvasnicka HM, Fischer R: Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders-aids to diagnosis and classification. Ann Hematol 1999, 78:495-506.
21. Thiele J, Kvasnicka HM, Diehl V: Bone marrow features of diagnostic impact in erythrocytosis. Ann Hematol 2005, 84:362-367.
22. Thiele J, Kvasnicka HM, Muehlhausen K, et al.: Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients. Pathol Res Pract 2001, 197:77-84.
23. Gruppo Italiano Studio Policitemia: Polycythemia vera: the natural history of 1213 patients followed for 20 years. Ann Intern Med 1995, 123:656-664.
24. Messinezy M, Pearson TC: The classification and diagnostic criteria of the erythrocytoses (polycythaemias). Clin Lab Haematol 1999, 21:309-316.
25. Berglund S, Zettervall O: Incidence of polycythemia vera in a defined population. Eur J Haematol 1992, 48:20-26.
26. Messinezy M, Sawyer B, Westwood NB, et al.: Idiopathic erythrocytosis-additional new study techniques suggest a heterogenous group. Eur J Haematol 1994, 53:163-167.
27. Najean Y, Triebel F, Dresch C: Pure erythrocytosis: reappraisal of a study of 51 cases. Am J Hematol 1981, 10:129-136.
28. Pearson TC, Wetherley-Mein G: The course and complications of idiopathic erythrocytosis. Clin Lab Haematol 1979, 1:189-196.
29. Ruggeri M, Tosetto A, Frezzato M, et al.: The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis. Ann Intern Med 2003, 139:470-475. This remarkable epidemiologic study of a large Italian city population is focused on the incidence of idiopathic erythrocytosis and evolving PV, according to the PVSG criteria, after a follow-up of about 5 years.
30. Thiele J, Kvasnicka HM, Diehl V: Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia. Acta Haematol 2005, 113:213-219. This is a systematic clinicopathologic study of latent (initial) PV presenting as ET, based on a large cohort of patients.
31. Murphy S, Peterson P, Hand H, et al.: Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 1997, 34:29-39.
32. Jantunen R, Juvonen E, Ikkala E, et al.: Development of erythrocytosis in the course of essential thrombocythemia. Ann Hematol 1999, 78:219-222.
33. Shih LY, Lee CT: Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay. Blood 1994, 83:744-748.
34. Griesshammer M, Klippel S, Strunck E, et al.: PRV-1 mRNA expression discriminates two types of essential thrombocythemia. Ann Hematol 2004, 83:364-370.
35. Goerttler PS, Steimle C, Marz E, et al.: The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients. Blood 2005, 106:2862-2864.
36. Imbert M, Pierre R, Thiele J, et al.: Essential thrombocythaemia. In WHO Classification of Tumours: Tumours of Hematopoietic and Lymphoid Tissue. Edited by Jaffe ES, Harris NL, Stein H, et al. Lyon, France: IARC Press; 2001:39-41.
37. Thiele J, Schneider G, Hoeppner B, et al: Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis-features of significance for the diagnosis of primary (essential) thrombocythaemia. Virchows Arch A Pathol Anat Histopathol 1988, 413:407-417.
38. Buhr T, Georgii A, Schuppan O, et al.: Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts. Ann Hematol 1992, 64:286-291.
39. Georgii A, Buhr T, Buesche G, et al.: Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies. Leuk Lymphoma 1996, 22(Suppl 1):15-29.
40. Thiele J, Kvasnicka HM, Diehl V, et al.: Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies. Leuk Lymphoma 1999, 33:207-218.
41. Bartl R, Frisch B, Wilmanns W: Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD). Eur J Haematol 1993, 50:41-52.
42. Dickstein JI, Vardiman JW: Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes. Am J Clin Pathol 1993, 99:513-525.
43. Ellis JT, Peterson P, Geller SA, et al.: Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies. Semin Hematol 1986, 23:144-155.
44. Buhr T, Georgii A, Choritz H: Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification. Pathol Res Pract 1993, 189:121-132.
45. Kreft A, Buche G, Ghalibafian M, et al.: The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies. Acta Haematol 2005, 113:137-143.
46. Thiele J, Kvasnicka HM, Facchetti F, et al.: European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 2005, 90:1128-1132.
47. Kreft A, Nolde C, Busche G, et al.: Polycythaemia vera: bone marrow histopathology under treatment with interferon, hydroxyurea and busulphan. Eur J Haematol 2000, 64:32-41.